FierceBiotech 2026年2月27日 As CAR-T cell therapy gains ground on solid tumors, regulatory red tape hinders progress
FierceBiotech 2026年2月27日 'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease review process
FierceBiotech 2026年2月26日 Sarepta CEO Doug Ingram to retire after a decade of Duchenne breakthroughs and controversies
FierceBiotech 2026年2月26日 Analysts see potential in MDMA drug after AtaiBeckley reports improvements in anxiety trial
FierceBiotech 2026年2月26日 Boehringer pens $500M pact with British biotech for oral approach to autoimmune diseases
FierceBiotech 2026年2月26日 Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial
FierceBiotech 2026年2月26日 Quantum Surgical snaps up J&J's NeuWave Medical for its microwave ablation technology
FierceBiotech 2026年2月26日 Protagonist plans to pocket $400M from Takeda rather than split US rusfertide profits
FierceBiotech 2026年2月26日 Accent halts solid tumor trial over adverse events, pivots to other lead cancer program
FierceBiotech 2026年2月25日 Worried Trump's MFN push will ‘destroy biotech innovation,’ midsize companies form coalition to fight back
FierceBiotech 2026年2月25日 Charles River sells manufacturing and discovery businesses to fulfill promised pivot
FierceBiotech 2026年2月25日 Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess
FierceBiotech 2026年2月25日 After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
FierceBiotech 2026年2月25日 GSK pays $950M in cash for Canadian biotech and its Winrevair-like blood pressure drug
FierceBiotech 2026年2月25日 After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst